Given the high prevalence of both diabetes and dementia in aging populations, this strategy may reduce long-term public health burdens, including healthcare costs, caregiver stress, and institutionalization needs. Szu-Yuan Wu, MD, MPH, PhD The researcher team also discovered that study participants taking GLP-1 agonists had a 25% lower risk of developing non-vascular dementias and a 12% lower chance of developing Alzheimers disease, compared to participants taking metformin
(1) y l cht c sn xut ti gan v tham gia vo nhiu qu trnh ca c th nh xy dng v sa cha m, sn xut cc cht ha hc v protein v h tr cho h thng min dch
No natural supplement exactly replicates GLP-1 drug effects- this distinction is important
By signing up, you will create a Euro Weekly News account if you don't already have one
A multidisciplinary care team comprised of a Care Coordinator - to facilitate the insurance process, as well as a Registered Dietitian, Fitness Specialist, and board-certified Clinician
Gut (2005) 54:90713.10.1136/gut.2004.058578 Summary Keywords ghrelin, glucagon-like peptide 1, GLUTag cells, oral glucose tolerance test, GHS-R1a Citation Lindqvist A, Shcherbina L, Fischer A-HT and Wierup N (2017) Ghrelin Is a Regulator of Glucagon-Like Peptide 1 Secretion and Transcription in Mice
